AAPM&R’s Spotlight Conference: Medical Cannabis Review 2022: Clinical Applications, Research, and Medicolegal Considerations-Session Recording

Video Transcription

Video Summary

The video discusses the availability and control of cannabis formulations, highlighting the challenges in finding specific strains with desired cannabinoid and terpene profiles. Some states with regulated medical cannabis programs offer information about the cannabinoid and terpene content of specific products to guide physicians and patients. Nabiximols, a product with standardized THC and CBD ratios, is available in some countries for specific medical conditions. It is important to consider patients' needs and preferences when recommending cannabis products.<br /><br />Dr. Misha Kogan discusses the use of medical cannabis in older adults for chronic pain, insomnia, and Alzheimer's disease symptoms. Age-related changes in the endocannabinoid system, such as a decrease in receptor density and endogenous cannabinoids, are highlighted. Data from an Israeli study shows that over 90% of older adult patients reported symptom improvement after using medical cannabis for six months. Dr. Kogan emphasizes the safety profile of medical cannabis in older adults, with generally mild side effects.<br /><br />Medical cannabis is discussed as an alternative to opioids for chronic pain, with lower doses and fewer side effects. A case study of a patient with peripheral neuropathy shows significant pain improvement with medical cannabis. CBD is mentioned as an effective option for insomnia, particularly for older adults who may not have access to standard treatments like cognitive behavioral therapy. Medical cannabis is also considered for treating symptoms of Alzheimer's disease, with a case study of a patient experiencing improved sleep and decreased agitation.<br /><br />The video concludes by thanking attendees of the Medical Cannabis Education Program and inviting them to reach out with questions or feedback.

Keywords

cannabis formulations

availability

specific strains

cannabinoid profiles

terpene profiles

regulated medical cannabis programs

physicians

patients

Nabiximols

medical conditions

older adults

chronic pain

insomnia

Alzheimer's disease symptoms

safety profile